{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"AR (androgen receptor), a transcription factor, is most frequently altered in advanced or castration-resistant prostate cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"11/16/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "22403669"
      ]
    },
    "description":"The AR L57Q mutation occurs within the amino-terminal domain of the protein. This mutation is found in prostate cancer. Expression of the L57Q mutation in simian cell lines demonstrated that it is inactivating as measured by decreased AR transcriptional activity compared to wildtype (PMID: 22403669).",
    "knownEffect":"Loss-of-function"
  },
  "oncogenic":"Likely Neutral",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"L57Q",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":367,
    "hgvs":"X:g.67545316T>A",
    "hugoSymbol":"AR",
    "id":null,
    "proteinEnd":57,
    "proteinStart":57,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The AR L57Q mutation is likely neutral.",
  "vus":false
}